Detection of down-regulated acetaldehyde dehydrogenase 1 in atopic dermatitis patients by two-dimensional electrophoresis

Experimental Dermatology

Volumn 16, Issue 2, 2007, Pages 130-134

  Park, Yong Doo ^a,b   Lyou, You Jeong ^b   Yang, Jun Mo ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Acetaldehyde dehydrogenase 1; Atopic dermatitis; Biomarker; Fibroblasts; Real time PCR; Two dimensional electrophoresis

Indexed keywords

ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKER; PROTEOME;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST CULTURE; HUMAN; NUCLEOTIDE SEQUENCE; PH; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CULTURE; TWO DIMENSIONAL ELECTROPHORESIS;

ADULT; ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HUMANS; ISOENZYMES; PROTEOMICS;

EID: 33845972235     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00524.x     Document Type: Article

References (12)

1. Leung D Y, Boguniewicz M, Howell M D et al. New insights into atopic dermatitis. J Clin Invest 2004: 113: 651-657.
2. Cookson W. The immunogenetics of asthma and eczema: A new focus on the epithelium. Nat Rev Immunol 2004: 4: 978-988.
3. Wright R J, Cohen R T, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005: 5: 23-29.
4. Blumenthal M N. The role of genetics in the development of asthma and atopy. Curr Opin Allergy Clin Immunol 2005: 5: 141-145.
5. Upham J W, Holt P G. Environment and development of atopy. Curr Opin Allergy Clin Immunol 2005: 5: 167-172.
6. Park Y D, Kim S Y, Jang H S et al. Towards a proteomic analysis of atopic dermatitis: A two-dimensional-polyacrylamide gel electrophoresis/ mass spectrometric analysis of cultured patient-derived fibroblasts. Proteomics 2004: 4: 3446-3455.
7. Park Y D, Lyou Y J, Lee K J et al. Towards profiling the gene expression of fibroblasts from atopic dermatitis patients: Human 8K complementary DNA microarray. Clin Exp Allergy 2006: 36: 649-657.
8. Park Y D, Jang H S, Kim S Y et al. Two-dimensional electrophoretic profiling of atopic dermatitis in primary cultured keratinocytes from patients. Proteomics 2006: 6: 1362-1370.
9. Seo E Y, Park G T, Lee K M et al. Identification of the target genes of atopic dermatitis by real-time PCR. J Invest Dermatol 2006: 126: 1187-1189.
10. Sugimoto M, Arai I, Futaki N et al. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis. Exp Dermatol 2005: 14: 898-905.
11. Galter D, Buervenich S, Carmine A et al. ALDH1 mRNA: Presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis 2003: 14: 637-647.
12. Fan X, Molotkov A, Manabe S I et al. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol Cell Biol 2003: 23: 4637-4648.